These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2548353)

  • 21. Non-pigmentary actions of alpha-melanocyte-stimulating hormone--lessons from the cutaneous melanocortin system.
    Böhm M; Schiller M; Luger TA
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):61-8. PubMed ID: 16914088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of colcemid on the centrosome and microtubules in dermal melanophores of Xenopus laevis larvae in vivo.
    Rubin KA; Starodubov SM; Onishchenko GE
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1099-117. PubMed ID: 10644015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation.
    Ao Y; Park HY; Olaizola-Horn S; Gilchrest BA
    Exp Cell Res; 1998 Oct; 244(1):117-24. PubMed ID: 9770355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
    Park HY; Russakovsky V; Ao Y; Fernandez E; Gilchrest BA
    Exp Cell Res; 1996 Aug; 227(1):70-9. PubMed ID: 8806453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-melanocyte stimulating hormone has beneficial effects on cerulein-induced acute pancreatitis.
    Jahovic N; Arbak S; Tekeli O; Alican I
    Peptides; 2004 Jan; 25(1):129-32. PubMed ID: 15003365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mechanism in control of human pigmentation by {beta}-melanocyte-stimulating hormone and 7-tetrahydrobiopterin.
    Spencer JD; Chavan B; Marles LK; Kauser S; Rokos H; Schallreuter KU
    J Endocrinol; 2005 Nov; 187(2):293-302. PubMed ID: 16293777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones.
    Ni XP; Butler AA; Cone RD; Humphreys MH
    J Hypertens; 2006 Nov; 24(11):2239-46. PubMed ID: 17053546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A glimpse into the underground market of melanotan.
    Callaghan Iii DJ
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
    Burian E; Burian E
    Lakartidningen; 2013 Jan 30-Feb 5; 110(5):208-10. PubMed ID: 23451671
    [No Abstract]   [Full Text] [Related]  

  • 31. Fitting MITF regulation of PDE4D3 into the skin pigmentation puzzle.
    Ohanna M; Bertolotto C; Ballotti R
    Pigment Cell Melanoma Res; 2011 Feb; 24(1):4-6. PubMed ID: 21040501
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.
    Minder EI; Barman-Aksoezen J; Schneider-Yin X
    Clin Pharmacokinet; 2017 Aug; 56(8):815-823. PubMed ID: 28063031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitiligo and sympathectomy. The effect of sympathectomy and alpha- melanocyte stimulating hormone.
    Lerner AB; Snell RS; Chanco-Turner ML; McGuire JS
    Arch Dermatol; 1966 Sep; 94(3):269-78. PubMed ID: 4378121
    [No Abstract]   [Full Text] [Related]  

  • 34. A review and update on melanocyte stimulating hormone therapy: afamelanotide.
    Fabrikant J; Touloei K; Brown SM
    J Drugs Dermatol; 2013 Jul; 12(7):775-9. PubMed ID: 23884489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Barbie drug melanotan--new internet drug with risky consequences].
    Knudsen K; Kjergaard C; Dalhoff K
    Lakartidningen; 2012 Oct 17-23; 109(42):1895-6. PubMed ID: 23193937
    [No Abstract]   [Full Text] [Related]  

  • 36. An in-depth case examination of an exotic dancer's experience of melanotan.
    Van Hout MC; Brennan R
    Int J Drug Policy; 2014 May; 25(3):444-50. PubMed ID: 24280586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin pigmentation and pharmacokinetics of melanotan-I in humans.
    Ugwu SO; Blanchard J; Dorr RT; Levine N; Brooks C; Hadley ME; Aickin M; Hruby VJ
    Biopharm Drug Dispos; 1997 Apr; 18(3):259-69. PubMed ID: 9113347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-melanocyte-stimulating hormone. A ubiquitous cytokine with pigmenting effects.
    Nordlund JJ
    JAMA; 1991 Nov; 266(19):2753-4. PubMed ID: 1658408
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-induced pseudoleucoderma: a commentary.
    Minder E
    Acta Derm Venereol; 2012 Mar; 92(2):220; author reply 220. PubMed ID: 22042164
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelins and α-melanocyte-stimulating hormone are increased in plasma of patients treated with UVA1 and psoralen plus UVA.
    Abdel-Naser MB; Seltmann H; Altenburg A; Zouboulis CC
    Photodermatol Photoimmunol Photomed; 2022 Nov; 38(6):611-613. PubMed ID: 35353376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.